ACM
INSP icon

AlphaCrest Capital Management’s Inspire Medical Systems INSP Stock Holding History

AlphaCrest Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,063
Closed -$427K – 1285
2021
Q1 		$427K Sell
2,063
-437
-17% -$92.9K 0.02% 877
2020
Q4 		$470K Buy
+2,500
New +$409K 0.04% 682

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

AlphaCrest Capital Management's INSP Position: Q2 2021 in Review

AlphaCrest Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2021, closing a stake of 2,063 shares — an estimated $427K sold.

AlphaCrest Capital Management first reported a position in INSP in Q4 2020 and held it in 2 quarters. The position peaked at $470K in Q4 2020. 247 funds tracked by Wall St. Rank hold INSP as of Q2 2021.

  • AlphaCrest Capital Management reported no remaining Inspire Medical Systems position as of Q2 2021 after selling out during the quarter.
  • AlphaCrest Capital Management sold 2,063 Inspire Medical Systems shares in Q2 2021, an estimated $427K.
  • AlphaCrest Capital Management first reported a position in Inspire Medical Systems in Q4 2020 and held it in 2 quarters.
  • AlphaCrest Capital Management's Inspire Medical Systems position peaked at $470K in Q4 2020.
  • 247 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2021.

Based on AlphaCrest Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.